As of Jun 24
| -0.28 / -2.01%|
The 5 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 21.00, with a high estimate of 30.00 and a low estimate of 16.00. The median estimate represents a +53.85% increase from the last price of 13.65.
The current consensus among 6 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.